Alpine Immune Sciences to Present at Two Upcoming Investor Conferences
SEATTLE--(BUSINESS WIRE)--Feb 27, 2019--Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for c…
